Published in Healthcare Finance, Tax and Law Weekly, July 11th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Fluidigm.
Report 1: Fluidigm Corporation has announced that the TOPAZ system has been used during the determination of the structure of the Polo-like Kinase 1 (Plk1), a protein known to play a significant role in the progression of the cell cycle. Increased levels of Plk1 have been associated with many cancers and are a negative prognostic indicator. The determination of the Plk1 structure may enable researchers to develop more effective drug therapies targeted towards the protein's active...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.